Fighting the Shadow: A Market-Oriented Look at the Lung Cancer Market Lung cancer remains one of the most formidable adversaries in global health, consistently ranking as the leading cause of cancer incidence and mortality worldwide. The sheer scale of its impact – with an estimated 2.48 million new cases and 1.8 million deaths globally in 2022 – underscores the urgent and continuous need for innovation in its diagnosis and treatment. This pressing...
0 Поделились
129 Просмотры